| Ferroptosis: mechanisms and links with diseases H Yan, T Zou, Q Tuo, S Xu, H Li, AA Belaidi, P Lei Signal transduction and targeted therapy 6 (1), 49, 2021 | 931 | 2021 |
| Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics AA Belaidi, AI Bush Journal of neurochemistry 139, 179-197, 2016 | 600 | 2016 |
| Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease M Jakaria, AA Belaidi, AI Bush, S Ayton Journal of neurochemistry 159 (5), 804-825, 2021 | 142 | 2021 |
| Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study BC Schwahn, FJ Van Spronsen, AA Belaidi, S Bowhay, J Christodoulou, ... The Lancet 386 (10007), 1955-1963, 2015 | 141 | 2015 |
| CuII(atsm) inhibits ferroptosis: Implications for treatment of neurodegenerative disease A Southon, K Szostak, KM Acevedo, KA Dent, I Volitakis, AA Belaidi, ... British journal of pharmacology 177 (3), 656-667, 2020 | 125 | 2020 |
| Cellular senescence and iron dyshomeostasis in Alzheimer’s disease S Masaldan, AA Belaidi, S Ayton, AI Bush Pharmaceuticals 12 (2), 93, 2019 | 97 | 2019 |
| Molybdenum in human health and disease G Schwarz, AA Belaidi Interrelations between essential metal ions and human diseases, 415-450, 2013 | 94 | 2013 |
| The complex role of apolipoprotein E in Alzheimer’s disease: an overview and update L Mahoney-Sanchez, AA Belaidi, AI Bush, S Ayton Journal of Molecular Neuroscience 60, 325-335, 2016 | 91 | 2016 |
| Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy AA Belaidi, S Masaldan, A Southon, P Kalinowski, K Acevedo, ... Molecular psychiatry 29 (2), 211-220, 2024 | 73 | 2024 |
| Marked age-related changes in brain iron homeostasis in amyloid protein precursor knockout mice AA Belaidi, AP Gunn, BX Wong, S Ayton, AT Appukuttan, BR Roberts, ... Neurotherapeutics 15, 1055-1062, 2018 | 73 | 2018 |
| S-sulfocysteine/NMDA receptor–dependent signaling underlies neurodegeneration in molybdenum cofactor deficiency A Kumar, B Dejanovic, F Hetsch, M Semtner, D Fusca, S Arjune, ... The Journal of clinical investigation 127 (12), 4365-4378, 2017 | 72 | 2017 |
| Characterization of selenium compounds for anti-ferroptotic activity in neuronal cells and after cerebral ischemia–reperfusion injury QZ Tuo, S Masaldan, A Southon, C Mawal, S Ayton, AI Bush, P Lei, ... Neurotherapeutics 18 (4), 2682-2691, 2021 | 69 | 2021 |
| Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy B Dejanovic, D Lal, CB Catarino, S Arjune, AA Belaidi, H Trucks, ... Neurobiology of disease 67, 88-96, 2014 | 66 | 2014 |
| Irregular RNA splicing curtails postsynaptic gephyrin in the cornu ammonis of patients with epilepsy B Förstera, AA Belaidi, R Jüttner, C Bernert, M Tsokos, TN Lehmann, ... Brain 133 (12), 3778-3794, 2010 | 64 | 2010 |
| Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations MA Greenough, DJR Lane, R Balez, HTD Anastacio, Z Zeng, K Ganio, ... Cell Death & Differentiation 29 (11), 2123-2136, 2022 | 62 | 2022 |
| Metal insertion into the molybdenum cofactor: product–substrate channelling demonstrates the functional origin of domain fusion in gephyrin AA Belaidi, G Schwarz Biochemical Journal 450 (1), 149-157, 2013 | 61 | 2013 |
| Low-molecular weight heparin increases circulating sFlt-1 levels and enhances urinary elimination H Hagmann, V Bossung, AA Belaidi, A Fridman, SA Karumanchi, ... PloS one 9 (1), e85258, 2014 | 56 | 2014 |
| Synthesis of cyclic pyranopterin monophosphate, a biosynthetic intermediate in the molybdenum cofactor pathway K Clinch, DK Watt, RA Dixon, SM Baars, GJ Gainsford, A Tiwari, ... Journal of medicinal chemistry 56 (4), 1730-1738, 2013 | 37 | 2013 |
| Acute phase markers in CSF reveal inflammatory changes in Alzheimer’s disease that intersect with pathology, APOE ε4, sex and age S Ayton, S Janelidze, B Roberts, S Palmqvist, P Kalinowski, I Diouf, ... Progress in Neurobiology 198, 101904, 2021 | 34 | 2021 |
| Molybdenum Cofactor Deficiency: A New HPLC Method for Fast Quantification of S-Sulfocysteine in Urine and Serum AA Belaidi, S Arjune, JA Santamaria-Araujo, JO Sass, G Schwarz JIMD Reports-Case and Research Reports, 2012/2, 35-43, 2012 | 31 | 2012 |
